- Home
- LMFA vs BCTX Comparison
LMFA vs BCTX Comparison
Compare LMFA & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- BCTX
- Stock Information
- Founded
- LMFA 2008
- BCTX 2014
- Country
- LMFA United States
- BCTX Canada
- Employees
- LMFA N/A
- BCTX N/A
- Industry
- LMFA Finance: Consumer Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- BCTX Health Care
- Exchange
- LMFA Nasdaq
- BCTX Nasdaq
- Market Cap
- LMFA 11.9M
- BCTX 13.7M
- IPO Year
- LMFA 2015
- BCTX N/A
- Fundamental
- Price
- LMFA $3.09
- BCTX $0.81
- Analyst Decision
- LMFA Hold
- BCTX Strong Buy
- Analyst Count
- LMFA 1
- BCTX 1
- Target Price
- LMFA N/A
- BCTX $32.00
- AVG Volume (30 Days)
- LMFA 5.2M
- BCTX 2.3M
- Earning Date
- LMFA 08-13-2025
- BCTX 06-16-2025
- Dividend Yield
- LMFA N/A
- BCTX N/A
- EPS Growth
- LMFA N/A
- BCTX N/A
- EPS
- LMFA N/A
- BCTX N/A
- Revenue
- LMFA $8,029,601.00
- BCTX N/A
- Revenue This Year
- LMFA $0.98
- BCTX N/A
- Revenue Next Year
- LMFA $4.31
- BCTX N/A
- P/E Ratio
- LMFA N/A
- BCTX N/A
- Revenue Growth
- LMFA N/A
- BCTX N/A
- 52 Week Low
- LMFA $1.02
- BCTX $0.69
- 52 Week High
- LMFA $5.14
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- LMFA 53.44
- BCTX 15.51
- Support Level
- LMFA $2.16
- BCTX $0.69
- Resistance Level
- LMFA $5.14
- BCTX $0.84
- Average True Range (ATR)
- LMFA 0.66
- BCTX 0.19
- MACD
- LMFA 0.13
- BCTX -0.09
- Stochastic Oscillator
- LMFA 33.01
- BCTX 5.15
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.